X

Building confidence in the COVID-19 vaccine through education

Megan Van Etten   |     March 22, 2021   |   SHARE THIS

Throughout the COVID-19 vaccine research and development process, the biopharmaceutical industry has worked to uphold the highest standards of research, clinical testing and manufacturing.

As new and ongoing vaccine candidates continue to advance through clinical development and regulatory review, educational outreach is critical to fully realizing the benefits these vaccines can provide. While recent data show public willingness to be vaccinated against COVID-19 is increasing, there is more that can be done. To increase vaccine confidence, the biopharmaceutical industry is committed to sharing open and honest information with all stakeholders so that people feel confident in getting a COVID-19 vaccine.

Since the start of the pandemic PhRMA has provided regular updates about industry progress toward researching and developing potential treatments and vaccines. You can see more at phrma.org/coronavirus.

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) recently kicked off its #TeamVaccines digital campaign, to help build global public confidence in COVID-19 vaccines by telling the stories of the people behind them. These biopharmaceutical workers have been affected by the pandemic in similar ways to us all — by balancing work and homeschooling, supporting family members and friends in unexpected ways, or dealing with illness and loss — all while working to help bring safe and effective vaccines to the world.

“At every step [of vaccine development], the work goes through rigorous research and development processes,” says Rita, a U.S.-based biopharmaceutical researcher who is part of the #TeamVaccines campaign. “This work is so important, for me, for my family and for us all.”

In December 2020, the Biotechnology Innovation Organization (BIO) launched COVIDVaccineFacts.org, an educational tool that links health care providers and the public to evidenced-based information about vaccines, including vaccine safety, efficacy, availability and affordability.

Amid the current pandemic, the biopharmaceutical industry has embraced its leadership role and remains committed to enhancing confidence and trust in the COVID-19 vaccines that our industry has worked tirelessly to develop, manufacturer and get to people around the world.

For more information about the COVID-19 vaccine development, visit phrma.org/coronavirus and www.cdc.gov/vaccines/covid-19.

Megan Van Etten

Megan Van Etten Megan Van Etten is senior director of public affairs at PhRMA. She is responsible for leading the association’s public affairs efforts on international issues, including trade, intellectual property and access to medicines. Prior to joining PhRMA, Megan was director of media and external communications at the U.S. Chamber of Commerce and communications director at the Beer Institute. She has also worked as a communications consultant for global public relations firms. When not at the office, Megan enjoys exploring new Washington, D.C. restaurants and traveling with her husband and friends.

Topics: Vaccines, COVID-19

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates